Despite global uncertainties, Healthcare Global is experiencing robust demand for its cancer care services, indicating a consistent focus on healthcare amid challenging times.

HealthCare Global Enterprises announces the appointment of Sanjeev Kumar as its new Chief Financial Officer, effective from May 25, 2026. The previous Interim CFO, Dr. Manish Mattoo, has stepped down. The board approved the decision on May 19, 2026.

HealthCare Global, a prominent oncology provider, is expanding with a new 200-bed facility and aiming to expand in Kenya and tier-2 cities like Mumbai, Vizag, Ranchi, and other unspecified locations. This expansion follows the sale of Milann for approximately ₹37 crore. The company's latest quarterly revenue increased by 18% year over year, resulting in a market capitalization of ₹9,748.7 crore.

HealthCare Global posted strong Q4 earnings, with plans to focus more on high-profit ventures and scale back lower-margin businesses for better long-term growth prospects.

Healthcare Global surpasses record Q4 revenue and profit in Q1 2026, signaling a robust recovery and increased investor trust in the hospital sector.

HCG, a leading healthcare provider, has inaugurated a state-of-the-art cancer treatment center in Bengaluru with an investment of INR 129 crores. Equipped with modern MRI and linear accelerators, the facility promises enhanced care for patients battling cancer.

HealthCare Global Enterprises (HCG) plans to sell its stake in BACC Health Care for approximately ₹37.6 crore, as per the Sales Purchase Agreement. This move supports HCG's strategic focus on cancer services and high-growth sectors.

HealthCare Global has announced the sale of its fertility business stake for approximately INR 376 crore, raising additional funds through a rights issue worth INR 416 crore. The company's audited FY26 results were approved, and an independent director was reappointed, along with the appointment of a new Chief Financial Officer and Investor Relations head.

Healthcare Global Enterprises experienced a significant 70.5% decrease in profits during the Q4 FY26, as indicated by recent financial reports. This substantial dip may indicate challenging times for the company.

HealthCare Global has reported a significant increase in revenue for FY26, up 15% year-over-year at approximately INR 25.45 billion. The company also showed a strong improvement in profitability, with adjusted EBITDA climbing by 19% to INR 4.71 billion and maintaining an impressive margin of 18.5%.

Healthcare Global announces a ₹37.6 crore agreement to offload BACC Health Care to Inviga, marking a significant change in the healthcare landscape.

HealthCare Global will release their Q4 earnings for FY26 on May 19, 2026. The trading window is currently closed and won't reopen until 48 hours after the results are announced.

HealthCare Global Enterprises has purchased a 34% stake in Vizag Hospital for approximately INR 154.5 crore, increasing its ownership to 85%. This acquisition, consistent with prior agreements, did not necessitate additional disclosures according to SEBI regulations.

Healthcare Global Enterprises has expanded its influence in Vizag Hospital by acquiring additional shares, marking their second investment in the medical facility and reinforcing their strategic position there.

HealthCare Global has purchased a 34% stake in Vizag Hospital for 155.7 crore INR, which boosts their ownership to 85%. This expansion broadens their healthcare services reach.